25.4% |
of the Singapore population suffers from at least one chronic condition.
1*
|
![]() |
-Diabetes: increase from 8.8% in 2017 to 9.5% during the period 2019-2020
|
![]() |
- Cardiovascular disease risk factors:
- Hypertension: significant increase from 2017 (24.2%) to 2019-2020 (35.5%).
- Hyperlipidaemia: blood cholesterol increased from 35.5% in 2017 to 39.1% in 2019-2020.
|
![]() |
- Alcoholism: increase in regular drinking from 2% in 2017 to 2.2% in 2020
|
![]() |
ACIP recommends Prevenar13 (PCV13) in series with PPSV23 for adults aged ≥19 years with an immunocompromising condition, CSF leak, or cochlear implant.
5
|
![]() |
Shared clinical decision-making is recommended regarding administration of PCV13 to persons aged ≥65 years who do not have an immunocompromising condition, cerebrospinal fluid leak, or cochlear implant and who have not previously received PCV13. If a decision to administer PCV13 is made, PCV13 should be administered first, followed by PPSV23 at least 1 year later.
5
|
ACIP=Advisory Committee on Immunization Practices; CDC=Centers for Disease Control and Prevention; CSF=cerebrospinal fluid; HIV=human immunodeficiency virus;
PCV13=13-valent pneumococcal conjugate vaccine; PPSV23=23-valent pneumococcal polysaccharide vaccine.
*Data from a retrospective cohort study from 3 large, longitudinal, US healthcare databases of medical and outpatient pharmacy claims from 2007-2010.
4
|